The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study - Summary - MDSpire

The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study

  • By

  • Filomena Napolitano

  • Emanuela Roscetto

  • Maria Fabozzi

  • Martina Aversa

  • Pietro Formisano

  • Maria Rosaria Catania

  • Nunzia Montuori

  • May 5, 2026

  • 0 min

Share

Objective:

To investigate the antimicrobial properties of Wharton’s jelly mesenchymal stem cell secretome (WJ-MSC-CM) and its potential application in regenerative medicine, highlighting its significance in addressing current challenges in the field.

Key Findings:
  • WJ-MSC-CM-treated fibroblasts showed increased ROS levels but enhanced antioxidant responses, with specific increases in [insert quantitative data].
  • WJ-MSC-CM protected fibroblasts from H2O2-induced cytotoxicity, demonstrating a [insert percentage] reduction in cell death.
  • Significant levels of antimicrobial peptides were found in WJ-MSC-CM, quantified at [insert specific levels].
  • WJ-MSC-CM demonstrated inhibitory activity against Staphylococcus aureus, with a [insert specific inhibition percentage].
Interpretation:

The findings highlight the antiseptic potential of WJ-MSC-CM, suggesting its role in modulating oxidative stress and enhancing host defense responses, which supports its application in regenerative therapies and warrants further exploration in clinical settings.

Limitations:
  • The study was conducted in vitro, limiting the applicability of results to in vivo scenarios, which may affect the translation of findings to clinical practice.
  • Further research is needed to fully characterize the mechanisms behind the antimicrobial effects, particularly in vivo studies to validate these findings.
Conclusion:

WJ-MSC-CM exhibits promising antimicrobial properties, supporting its potential as a cell-free strategy in regenerative medicine, particularly in treating infections associated with chronic wounds.

Original Source(s)

Related Content